The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model.

导出 OA

翻译打印收藏纠错

作者： Vanessa,Andrés-Guerrero ^[1] ; Irene,Camacho-Bosca ^[2] ; Liseth,Salazar-Quiñones ^[3] ; Nestor,Ventura-Abreu ^[3] ; Mercedes,Molero-Senosiain ^[3] ; Samuel,Hernández-Ruiz ^[3] ; Guillermo,Bernal-Sancho ^[3] ; Rocío,Herrero-Vanrell ^[3] ; Julián,García-Feijóo ^[1]

作者单位： Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid (UCM), IdISSC, 28040 Madrid, Spain. ^[1] Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group (UCM 920415), 28040 Madrid, Spain. ^[2] Ophthalmology Department, San Carlos Clinical Hospital, 28040 Madrid, Spain. ^[3] Department of Immunology, Ophthalmology and ORL, Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Faculty of Medicine, Complutense University of Madrid (UCM), IdISSC, 28040 Madrid, Spain. ^[4]

关键词 anti-VEGF bevacizumab collagen implant drug release inflammation intraocular pressure sodium hyaluronate trabeculectomy

DOI 10.3390/pharmaceutics13060896

PMID 34204254

发布时间 2021-07-14

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交